CRONOS GROUP INC

How Cronos Group’s $75M blockchain breach reshaped its strategy: rapid rollback, stablecoin focus, and Crypto.com partnership to protect users and boost market growth.

How Cronos Group’s $75 M Tectonic hack halted its blockchain, risked CRO token liquidity, and sparked a strategic pivot toward stablecoins.

Cronos Group Inc. invites investors to its AGM on September 28, 2026, where audited financials, board elections, and cannabis‑industry strategy will be discussed.

CRON reports a Q2 2026 earnings beat—GAAP EPS of $0.09 and $53M revenue, lifting its TSX share 13.2% to $3.80 as the cannabis firm strengthens security and growth plans.

Discover why Cronos Group’s stock volatility and shocking negative P/E reveal hidden financial risks, yet a market‑valued future still beckons Canadian cannabis investors.

Explore Cronos Group Inc.’s role in Canada’s cannabis market, its fluctuating stock, and challenges to profitability—key insights for investors and industry watchers.

Explore how Cronos Group’s vertical integration and focus on high‑quality cannabis products position it for growth in Canada’s expanding medical marijuana market.

Check out how Cronos Group’s Q1 2026 earnings beat expectations, spike shares, and spark a $50 m buy‑back – but watch rising costs and volatile P/E for hidden risks.

Cronos Group’s Q4 earnings miss reveals forex‑driven earnings pressure, yet revenue beats and strategic moves—including a European acquisition and Cyprus gas project—signal growth potential.

Explore how Cronos Group’s launch of Lord Jones® in Israel and new crypto ventures bolster its global strategy and solid fundamentals for investors.